Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT00287989 · COMPLETED
Trial details
- NCT number
- NCT00287989
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2007-08-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.